BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

582 related articles for article (PubMed ID: 24106397)

  • 1. Probiotics and irritable bowel syndrome.
    Dai C; Zheng CQ; Jiang M; Ma XY; Jiang LJ
    World J Gastroenterol; 2013 Sep; 19(36):5973-80. PubMed ID: 24106397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intestinal microbiota in pathophysiology and management of irritable bowel syndrome.
    Lee KN; Lee OY
    World J Gastroenterol; 2014 Jul; 20(27):8886-97. PubMed ID: 25083061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of irritable bowel syndrome with probiotics. An etiopathogenic approach at last?
    Bixquert Jiménez M
    Rev Esp Enferm Dig; 2009 Aug; 101(8):553-64. PubMed ID: 19785495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irritable bowel syndrome: the evolution of multi-dimensional looking and multidisciplinary treatments.
    Chang FY
    World J Gastroenterol; 2014 Mar; 20(10):2499-514. PubMed ID: 24627587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unraveling the ties between irritable bowel syndrome and intestinal microbiota.
    Hong SN; Rhee PL
    World J Gastroenterol; 2014 Mar; 20(10):2470-81. PubMed ID: 24627584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucosal permeability and immune activation as potential therapeutic targets of probiotics in irritable bowel syndrome.
    Barbara G; Zecchi L; Barbaro R; Cremon C; Bellacosa L; Marcellini M; De Giorgio R; Corinaldesi R; Stanghellini V
    J Clin Gastroenterol; 2012 Oct; 46 Suppl():S52-5. PubMed ID: 22955358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis.
    Didari T; Mozaffari S; Nikfar S; Abdollahi M
    World J Gastroenterol; 2015 Mar; 21(10):3072-84. PubMed ID: 25780308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized double-blind placebo-controlled clinical trial on efficacy and safety of association of simethicone and Bacillus coagulans (Colinox®) in patients with irritable bowel syndrome.
    Urgesi R; Casale C; Pistelli R; Rapaccini GL; de Vitis I
    Eur Rev Med Pharmacol Sci; 2014; 18(9):1344-53. PubMed ID: 24867512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastrointestinal microbiota in irritable bowel syndrome: their role in its pathogenesis and treatment.
    Parkes GC; Brostoff J; Whelan K; Sanderson JD
    Am J Gastroenterol; 2008 Jun; 103(6):1557-67. PubMed ID: 18513268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of the gut microbiota: a focus on treatments for irritable bowel syndrome.
    Harris LA; Baffy N
    Postgrad Med; 2017 Nov; 129(8):872-888. PubMed ID: 28936910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is irritable bowel syndrome an infectious disease?
    Thompson JR
    World J Gastroenterol; 2016 Jan; 22(4):1331-4. PubMed ID: 26819502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review article: evidence for the role of gut microbiota in irritable bowel syndrome and its potential influence on therapeutic targets.
    Dupont HL
    Aliment Pharmacol Ther; 2014 May; 39(10):1033-42. PubMed ID: 24665829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of commensals and probiotics on visceral sensitivity and pain in irritable bowel syndrome.
    Theodorou V; Ait Belgnaoui A; Agostini S; Eutamene H
    Gut Microbes; 2014; 5(3):430-6. PubMed ID: 25184834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treating irritable bowel syndrome with probiotics: the evidence.
    Parkes GC; Sanderson JD; Whelan K
    Proc Nutr Soc; 2010 May; 69(2):187-94. PubMed ID: 20236566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probiotics, Prebiotics, and Synbiotics: Implications and Beneficial Effects against Irritable Bowel Syndrome.
    Simon E; Călinoiu LF; Mitrea L; Vodnar DC
    Nutrients; 2021 Jun; 13(6):. PubMed ID: 34203002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intestinal microbiota and its role in irritable bowel syndrome (IBS).
    Ohman L; Simrén M
    Curr Gastroenterol Rep; 2013 May; 15(5):323. PubMed ID: 23580243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stress and the gut: pathophysiology, clinical consequences, diagnostic approach and treatment options.
    Konturek PC; Brzozowski T; Konturek SJ
    J Physiol Pharmacol; 2011 Dec; 62(6):591-9. PubMed ID: 22314561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probiotics in Irritable Bowel Syndrome: The Science and the Evidence.
    Quigley EM
    J Clin Gastroenterol; 2015; 49 Suppl 1():S60-4. PubMed ID: 26447967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Irritable bowel syndrome: a concise review of current treatment concepts.
    Wall GC; Bryant GA; Bottenberg MM; Maki ED; Miesner AR
    World J Gastroenterol; 2014 Jul; 20(27):8796-806. PubMed ID: 25083054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging Role of the Gut Microbiome in Irritable Bowel Syndrome.
    Singh P; Lembo A
    Gastroenterol Clin North Am; 2021 Sep; 50(3):523-545. PubMed ID: 34304786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.